Thyroid Disease
| Pembrolizumab | PD-1 checkpoint inhibitor | High PD-L1 non-small cell lung cancer | Immune-related colitis, pneumonitis, thyroid disease |
What our notes say
- | Pembrolizumab | PD-1 checkpoint inhibitor | High PD-L1 non-small cell lung cancer | Immune-related colitis, pneumonitis, thyroid disease | (Lung Cancer)
- Medical conditions and drugs: control diabetes, hypertension, epilepsy, thyroid disease and asthma, and avoid teratogenic drugs. (Reproductive Health 1 End of Trimester CAT: November 2018)
- Endocrine and chronic disease: diabetes, thyroid disease, PCOS, antiphospholipid syndrome (Reproductive Health 1 End of Trimester CAT: ectopic pregnancy, ANC and abortion )
- Previous pelvic infection or STI, abdominal or pelvic surgery, contraception history, and medical conditions (thyroid disease, diabetes). (Integrated case paper: Medicine, Surgery, Gynaecology and Paediatrics (160 marks)
- Topics tested: diabetes (type 1 and 2, drugs, DKA, hyperosmolar state, hypoglycaemia), adrenal disease and Addisonian crisis, thyroid disease and myxoedema coma, and parathyroid disease. (Internal Medicine 4th Year Endocrinology CAT: 30 MCQs)
- Topics tested: respiratory disease, sickle cell disease and anaemias, rheumatic fever, diabetes, TB, pulmonary embolism, connective tissue disease, HIV, gastroenterology, thyroid disease, gout, leukaemia and lymphoma, kidney disease and stroke. (Internal Medicine (MBIM 4100) main exam, Paper One: 3 July 2019)